262 related articles for article (PubMed ID: 16237195)
1. Hexachlorobenzene is a tumor co-carcinogen and induces alterations in insulin-growth factors signaling pathway in the rat mammary gland.
Randi AS; Cocca C; Carbone V; Nuñez M; Croci M; Gutiérrez A; Bergoc R; Kleiman de Pisarev DL
Toxicol Sci; 2006 Jan; 89(1):83-92. PubMed ID: 16237195
[TBL] [Abstract][Full Text] [Related]
2. Alterations in c-Src/HER1 and estrogen receptor α signaling pathways in mammary gland and tumors of hexachlorobenzene-treated rats.
Peña D; Pontillo C; García MA; Cocca C; Alvarez L; Chiappini F; Bourguignon N; Frahm I; Bergoc R; Kleiman de Pisarev D; Randi A
Toxicology; 2012 Mar; 293(1-3):68-77. PubMed ID: 22245120
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
Chan TW; Pollak M; Huynh H
Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
[TBL] [Abstract][Full Text] [Related]
4. Hexachlorobenzene induces cell proliferation and IGF-I signaling pathway in an estrogen receptor alpha-dependent manner in MCF-7 breast cancer cell line.
García MA; Peña D; Alvarez L; Cocca C; Pontillo C; Bergoc R; de Pisarev DK; Randi A
Toxicol Lett; 2010 Feb; 192(2):195-205. PubMed ID: 19879930
[TBL] [Abstract][Full Text] [Related]
5. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I receptor expression and localization in benign and malignant rat mammary tumors.
Cocca C; Randi A; Gutiérrez A; Núñez M; Croci M; Martín G; Cricco G; Medina V; Mohamad N; Rivera E; Kleiman D; Bergoc R
Anticancer Res; 2005; 25(6B):4305-12. PubMed ID: 16309233
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
[TBL] [Abstract][Full Text] [Related]
8. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
Sun H; Tu X; Liu M; Baserga R
J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV
Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456
[TBL] [Abstract][Full Text] [Related]
10. Activation of c-Src/HER1/STAT5b and HER1/ERK1/2 signaling pathways and cell migration by hexachlorobenzene in MDA-MB-231 human breast cancer cell line.
Pontillo CA; García MA; Peña D; Cocca C; Chiappini F; Alvarez L; Kleiman de Pisarev D; Randi AS
Toxicol Sci; 2011 Apr; 120(2):284-96. PubMed ID: 21205633
[TBL] [Abstract][Full Text] [Related]
11. N-nitroso-N-methylurea-induced mammary carcinogenesis: effect of prolactin on expression of Ia antigen by tumor cells.
Bernard DJ; Maurizis JC; Chassagne J; Chollet P; Plagne R
J Natl Cancer Inst; 1986 Jun; 76(6):1237-42. PubMed ID: 3012179
[TBL] [Abstract][Full Text] [Related]
12. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
[TBL] [Abstract][Full Text] [Related]
13. Increased IRS-2 content and activation of IGF-I pathway contribute to enhance beta-cell mass in fetuses from undernourished pregnant rats.
Fernández E; Martín MA; Fajardo S; Escrivá F; Alvarez C
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E187-95. PubMed ID: 16912057
[TBL] [Abstract][Full Text] [Related]
14. Hexachlorobenzene triggers apoptosis in rat thyroid follicular cells.
Chiappini F; Alvarez L; Lux-Lantos V; Randi AS; Kleiman de Pisarev DL
Toxicol Sci; 2009 Apr; 108(2):301-10. PubMed ID: 19182106
[TBL] [Abstract][Full Text] [Related]
15. Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.
Surmacz E; Bartucci M
J Exp Clin Cancer Res; 2004 Sep; 23(3):385-94. PubMed ID: 15595626
[TBL] [Abstract][Full Text] [Related]
16. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
17. Effect of tamoxifen on preneoplastic cell proliferation in N-nitroso-N-methylurea-induced mammary carcinogenesis.
Osborne MP; Ruperto JF; Crowe JP; Rosen PP; Telang NT
Cancer Res; 1992 Mar; 52(6):1477-80. PubMed ID: 1540955
[TBL] [Abstract][Full Text] [Related]
18. Hexachlorobenzene-induced early changes in ornithine decarboxylase and protein tyrosine kinase activities, polyamines and c-Myc, c-Fos and c-Jun proto-oncogenes in rat liver.
Randi AS; Hernandez S; Alvarez L; Sanchez M; Schwarcz M; Kleiman d Pisarev DL
Toxicol Sci; 2003 Dec; 76(2):291-8. PubMed ID: 14600289
[TBL] [Abstract][Full Text] [Related]
19. In situ phosphorylation of Akt and ERK1/2 in rat mammary gland, colon, and liver following treatment with human insulin and IGF-1.
Hvid H; Fels JJ; Kirk RK; Thorup I; Jensen HE; Hansen BF; Oleksiewicz MB
Toxicol Pathol; 2011 Jun; 39(4):623-40. PubMed ID: 21558470
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of the insulin receptor and type I insulin-like growth factor receptor are early events in hepatocarcinogenesis.
Aleem E; Nehrbass D; Klimek F; Mayer D; Bannasch P
Toxicol Pathol; 2011 Apr; 39(3):524-43. PubMed ID: 21411721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
